Amprius Technologies, Inc. — Form 8-K Summary
Business Context and Reporting Period
Amprius Technologies, Inc. filed a Current Report on Form 8-K dated May 13, 2024. The filing reports an amendment to the terms of the company’s public and private placement warrants.
Key Financial Metrics and Capital Structure
This filing does not provide revenue, profit, cash flow, margin, debt, liquidity, or other operating financial metrics. It also does not include financial statements.
The company’s common stock trades under the symbol AMPX and its redeemable warrants trade under AMPX.W on the New York Stock Exchange.
Material Changes Versus the Prior Comparable Period
Amprius and Continental Stock Transfer & Trust Company entered into an amendment to the March 1, 2022 Warrant Agreement. The cash exercise price for the company’s public and private placement warrants was temporarily reduced from $11.50 to $1.10 per warrant when exercised under the related offer.
The reduced exercise price applies from May 13, 2024 through 5:00 p.m. Eastern Time on June 11, 2024, unless the company extends the offer. After the expiration date, the warrants may no longer be exercised for cash at the reduced price. All other warrant terms remain unchanged.
Guidance, Outlook, Risks, and Unusual Items
- The offer may result in warrant exercises and related proceeds, but the filing does not state the number of eligible warrants or quantify expected proceeds.
- The expiration date may be extended solely at the company’s discretion.
- Investors should consider potential dilution from warrant exercises and the effect of the temporary exercise-price reduction.
- The filing does not provide management guidance, operating outlook, or new business-risk disclosures.
Important Facts to Verify
- Review the Offer to Exercise and the First Amendment to the Warrant Agreement filed with the SEC.
- Verify the number of public and private placement warrants eligible for the $1.10 exercise price.
- Confirm whether the offer expiration date was extended and determine the resulting warrant exercise activity.
- Assess potential share issuance, dilution, and cash proceeds from exercised warrants.